Batavia Biosciences, a contract development and manufacturing organization (CDMO), has released Amalia, a GMP-ready manufacturing facility in Bilthoven, Netherlands, expanding capabilities to deliver clinical manufacturing of viral vaccines and viral vectors.  The facility houses advanced equipment and adheres to stringent quality standards for viral vector and vaccine development and production. Amalia maintains up to Grade B cleanroom standards to ensure sterile and safe production envir...